XORTX Therapeutics XRTX
NASDAQ XRTX
$0.97 +0.04 (+4.30%)
At close: Oct 22, 2026 · 4:00 PM EDT

XORTX Therapeutics (XRTX) Price to Earnings (2022)

Updated

XORTX Therapeutics' (XRTX) Price to Earnings was 1.40 for the year ended Dec 31, 2025, up 4.1% from 1.34 a year earlier.

Analysis

XORTX Therapeutics (XRTX) Price to Earnings (2022) Analysis & Trends

  • According to Business Quant data, Price to Earnings came in at 1.34 in the year ended Dec 31, 2024 (-53.4%) and 2.89 in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 XORTX Therapeutics 1.35 Mn -1.95 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 68.21
API Access

XORTX Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=XRTX&period=max&api_key=YOUR_API_KEY